Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of BRL 913.77 billion. The enterprise value is 1.14 trillion.

Market Cap	913.77B
Enterprise Value	1.14T

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Feb 12, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	81.91%
Float	538.24M

Valuation Ratios

The trailing PE ratio is 21.51 and the forward PE ratio is 15.21.

PE Ratio	21.51
Forward PE	15.21
PS Ratio	4.51
PB Ratio	19.16
P/TBV Ratio	n/a
P/FCF Ratio	20.48
P/OCF Ratio	16.66
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.63, with an EV/FCF ratio of 25.65.

EV / Earnings	26.94
EV / Sales	6.26
EV / EBITDA	13.63
EV / EBIT	19.86
EV / FCF	25.65

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	6.33%
Revenue Per Employee	6.43M
Profits Per Employee	1.35M
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 6.97 billion in taxes.

Income Tax	6.97B
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +9.93% in the last 52 weeks. The beta is 0.47, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	+9.93%
50-Day Moving Average	67.02
200-Day Moving Average	60.76
Relative Strength Index (RSI)	36.67
Average Volume (20 Days)	325

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.69

Income Statement

In the last 12 months, Amgen had revenue of BRL 202.42 billion and earned 42.47 billion in profits. Earnings per share was 78.38.

Revenue	202.42B
Gross Profit	143.29B
Operating Income	63.75B
Pretax Income	49.44B
Net Income	42.47B
EBITDA	91.53B
EBIT	63.75B
Earnings Per Share (EPS)	78.38

Balance Sheet

The company has 50.28 billion in cash and 305.34 billion in debt, giving a net cash position of -255.05 billion.

Cash & Cash Equivalents	50.28B
Total Debt	305.34B
Net Cash	-255.05B
Net Cash Per Share	n/a
Equity (Book Value)	47.69B
Book Value Per Share	88.51
Working Capital	19.65B

Cash Flow

In the last 12 months, operating cash flow was 54.85 billion and capital expenditures -10.23 billion, giving a free cash flow of 44.61 billion.

Operating Cash Flow	54.85B
Capital Expenditures	-10.23B
Depreciation & Amortization	25.13B
Net Borrowing	-28.32B
Free Cash Flow	44.61B
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 1.25, which amounts to a dividend yield of 2.06%.

Dividend Per Share	1.25
Dividend Yield	2.06%
Dividend Growth (YoY)	-0.37%
Years of Dividend Growth	12
Payout Ratio	1.60%
Buyback Yield	-0.19%
Shareholder Yield	1.83%
Earnings Yield	4.65%
FCF Yield	4.88%

Dividend Details

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 28.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	28

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7